BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 27245865)

  • 1. Dupuytren's disease susceptibility gene, EPDR1, is involved in myofibroblast contractility.
    Staats KA; Wu T; Gan BS; O'Gorman DB; Ophoff RA
    J Dermatol Sci; 2016 Aug; 83(2):131-7. PubMed ID: 27245865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dupuytren's fibroblast contractility by sphingosine-1-phosphate is mediated through non-muscle myosin II.
    Komatsu I; Bond J; Selim A; Tomasek JJ; Levin LS; Levinson H
    J Hand Surg Am; 2010 Oct; 35(10):1580-8. PubMed ID: 20888494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common variants of the EPDR1 gene and the risk of Dupuytren’s disease.
    Dębniak T; Żyluk A; Puchalski P; Serrano-Fernandez P
    Handchir Mikrochir Plast Chir; 2013 Oct; 45(5):253-7. PubMed ID: 24089297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical changes in the collagen of the palmar fascia in patients with Dupuytren's disease.
    Brickley-Parsons D; Glimcher MJ; Smith RJ; Albin R; Adams JP
    J Bone Joint Surg Am; 1981 Jun; 63(5):787-97. PubMed ID: 7240301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of histological patterns in clinically affected and unaffected palm regions in dupuytren's disease.
    Alfonso-Rodríguez CA; Garzón I; Garrido-Gómez J; Oliveira AC; Martín-Piedra MÁ; Scionti G; Carriel V; Hernández-Cortés P; Campos A; Alaminos M
    PLoS One; 2014; 9(11):e112457. PubMed ID: 25379672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tamoxifen decreases fibroblast function and downregulates TGF(beta2) in dupuytren's affected palmar fascia.
    Kuhn MA; Wang X; Payne WG; Ko F; Robson MC
    J Surg Res; 2002 Apr; 103(2):146-52. PubMed ID: 11922728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MMP-14 and MMP-2 are key metalloproteases in Dupuytren's disease fibroblast-mediated contraction.
    Wilkinson JM; Davidson RK; Swingler TE; Jones ER; Corps AN; Johnston P; Riley GP; Chojnowski AJ; Clark IM
    Biochim Biophys Acta; 2012 Jun; 1822(6):897-905. PubMed ID: 22342364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Periostin differentially induces proliferation, contraction and apoptosis of primary Dupuytren's disease and adjacent palmar fascia cells.
    Vi L; Feng L; Zhu RD; Wu Y; Satish L; Gan BS; O'Gorman DB
    Exp Cell Res; 2009 Dec; 315(20):3574-86. PubMed ID: 19619531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of alpha-smooth muscle actin expression and contraction in Dupuytren's disease fibroblasts.
    Tomasek J; Rayan GM
    J Hand Surg Am; 1995 May; 20(3):450-5. PubMed ID: 7642925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of contractile force by cultured Dupuytren's disease and normal palmar fibroblasts.
    Rayan GM; Tomasek JJ
    Tissue Cell; 1994 Oct; 26(5):747-56. PubMed ID: 9437248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA sequencing reveals a depletion of collagen targeting microRNAs in Dupuytren's disease.
    Riester SM; Arsoy D; Camilleri ET; Dudakovic A; Paradise CR; Evans JM; Torres-Mora J; Rizzo M; Kloen P; Julio MK; van Wijnen AJ; Kakar S
    BMC Med Genomics; 2015 Oct; 8():59. PubMed ID: 26446724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of bone morphogenetic proteins by Dupuytren's fibroblasts.
    Shin SS; Liu C; Chang EY; Carlson CS; Di Cesare PE
    J Hand Surg Am; 2004 Sep; 29(5):809-14. PubMed ID: 15465229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrative analysis of Dupuytren's disease identifies novel risk locus and reveals a shared genetic etiology with BMI.
    Major M; Freund MK; Burch KS; Mancuso N; Ng M; Furniss D; Pasaniuc B; Ophoff RA
    Genet Epidemiol; 2019 Sep; 43(6):629-645. PubMed ID: 31087417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-transcriptional regulation of alpha-smooth muscle actin determines the contractile phenotype of Dupuytren's nodular cells.
    Verjee LS; Midwood K; Davidson D; Eastwood M; Nanchahal J
    J Cell Physiol; 2010 Sep; 224(3):681-90. PubMed ID: 20432463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The collagen changes of Dupuytren's contracture.
    Murrell GA; Francis MJ; Bromley L
    J Hand Surg Br; 1991 Aug; 16(3):263-6. PubMed ID: 1960490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of interferon-alpha2b on an in vitro model Dupuytren's contracture.
    Sanders JL; Dodd C; Ghahary A; Scott PG; Tredget EE
    J Hand Surg Am; 1999 May; 24(3):578-85. PubMed ID: 10357539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgen receptors in Dupuytren's contracture.
    Pagnotta A; Specchia N; Greco F
    J Orthop Res; 2002 Jan; 20(1):163-8. PubMed ID: 11853085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Free radicals and Dupuytren's contracture.
    Murrell GA; Francis MJ; Bromley L
    Br Med J (Clin Res Ed); 1987 Nov; 295(6610):1373-5. PubMed ID: 2825907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The pathobiochemistry of Dupuytren's contracture].
    Bobiński R
    Chir Narzadow Ruchu Ortop Pol; 2009; 74(2):68-73. PubMed ID: 19514484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium-dependent signaling in Dupuytren's disease.
    Hadeed JG; Bond JE; Selim MA; Bergeron A; Levin LS; Levinson H
    Hand (N Y); 2011 Jun; 6(2):159-64. PubMed ID: 22654698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.